Introduction: Buprenorphine-naloxone is recommended as a first-line agent for the treatment of opioid use disorder. Although initiation of buprenorphine in the emergency department (ED) is evidence based, barriers to implementation persist. A comprehensive review and critical analysis of both facilitators of and barriers to buprenorphine initiation in ED has yet to be published. Our objectives are (1) to map the implementation of buprenorphine induction pathway literature and synthesise what we know about buprenorphine pathways in EDs and (2) to identify gaps in this literature with respect to barriers and facilitators of implementation. Methods and analysis: We will conduct a scoping review to comprehensively search the literature, map ...
Introduction: Prescribing of buprenorphine and naloxone in the emergency department (ED) has been sh...
Buprenorphine has become an important medication in the context of the ongoing opioid epidemic. Howe...
Introduction: Medications for opioid use disorder (MOUD), including buprenorphine, represent an evid...
Introduction: Opioid abuse and overdose deaths have reached epidemic proportions in the last couple ...
Introduction: Substance use disorders, including opioid use disorders, are a major public health con...
Introduction: Emergency care providers routinely treat patients with acute presentations and sequela...
Introduction: Emergency care providers routinely treat patients with acute presentations and sequela...
Introduction: Substance use disorders, including opioid use disorders, are a major public health con...
Emergency departments (ED) are increasingly providing buprenorphine to persons with opioid use disor...
Introduction: Substance use disorders, including opioid use disorders, are a major public health con...
Emergency departments (ED) are increasingly providing buprenorphine to persons with opioid use disor...
Background: Opioid-involved deaths in the United States have risen steadily since 2018, from 47,000 ...
Introduction: Emergency department (ED) visits related to opioid use disorder (OUD) have increased n...
Introduction: Emergency department (ED) visits related to opioid use disorder (OUD) have increased n...
Abstract Background Patients with opioid use disorder (OUD) frequently present to the emergency depa...
Introduction: Prescribing of buprenorphine and naloxone in the emergency department (ED) has been sh...
Buprenorphine has become an important medication in the context of the ongoing opioid epidemic. Howe...
Introduction: Medications for opioid use disorder (MOUD), including buprenorphine, represent an evid...
Introduction: Opioid abuse and overdose deaths have reached epidemic proportions in the last couple ...
Introduction: Substance use disorders, including opioid use disorders, are a major public health con...
Introduction: Emergency care providers routinely treat patients with acute presentations and sequela...
Introduction: Emergency care providers routinely treat patients with acute presentations and sequela...
Introduction: Substance use disorders, including opioid use disorders, are a major public health con...
Emergency departments (ED) are increasingly providing buprenorphine to persons with opioid use disor...
Introduction: Substance use disorders, including opioid use disorders, are a major public health con...
Emergency departments (ED) are increasingly providing buprenorphine to persons with opioid use disor...
Background: Opioid-involved deaths in the United States have risen steadily since 2018, from 47,000 ...
Introduction: Emergency department (ED) visits related to opioid use disorder (OUD) have increased n...
Introduction: Emergency department (ED) visits related to opioid use disorder (OUD) have increased n...
Abstract Background Patients with opioid use disorder (OUD) frequently present to the emergency depa...
Introduction: Prescribing of buprenorphine and naloxone in the emergency department (ED) has been sh...
Buprenorphine has become an important medication in the context of the ongoing opioid epidemic. Howe...
Introduction: Medications for opioid use disorder (MOUD), including buprenorphine, represent an evid...